Form 8-K - Current report:
SEC Accession No. 0000950170-25-083214
Filing Date
2025-06-06
Accepted
2025-06-06 16:53:33
Documents
10
Period of Report
2025-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K achv-20250604.htm   iXBRL 8-K 109990
  Complete submission text file 0000950170-25-083214.txt   258466

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT achv-20250604.xsd EX-101.SCH 51394
13 EXTRACTED XBRL INSTANCE DOCUMENT achv-20250604_htm.xml XML 6344
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 251031816
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)